Objective: The prognostic value of red cell distribution width to platelet count ratio (RPR) in patients with breast cancer is not clear. This study aims to evaluate the prognostic significance of red cell distribution width to platelet count ratio in breast cancer patients. Material and Methods: A retrospective analysis was performed on 150 patients with non-metastatic breast cancer between January 2014-December 2018. The optimal cut off value of RPR was 0.54 for diseasefree survival (DFS). The chi-square test or Fisher's exact test was used to evaluate relationships between the RPR and other clinicopathological variables. Kaplan-Meier log-rank test was used to determine the effect of variables on DFS. Cox's proportional hazards model was used for multivariate analysis. Results: Median follow-up period was 39±1.174 (13-66) months and 5-year survival was 96.60%. There was no relationships between the RPR and clinicopathological variables. Kaplan-Meier analysis showed significant correlation between elevated RPR level (p=0.001) and high MPV(mean platelet volume)/Platelet(P) ratio (p=0.006) and DFS. DFS was found to be short in patients with high RPR and high MPV/P ratio. When multivariate analysis was performed with cox regression analysis, RPR level (p=0.025) and tumor size (p=0.047) were found to be independent prognostic factors . RPR was found to be a more valuable prognostic marker than mean platelet volume to platelet ratio (MPV/P). Conclusion: We found that high RPR levels before adjuvant treatment were associated with poor DFS in patients with curative resected breast cancer. Accordingly, the RPR level can be used as a prognostic marker in non-metastatic breast cancer. However, further studies conducted with a larger number of patients are needed.
Keywords: Breast cancer; red cell distribution width; platelet; prognosis
Amaç: Meme kanserli hastalarda kırmızı küre dağılım genişliğinin trombosit sayısına oranı (RPR)'nın prognostik değeri net olarak bilinmemektedir. Bu çalışmada amacımız kırmızı küre dağılım genişliğinin trombosit sayısına oranının meme kanserli hastalarda prognostik önemini değerlendirmektir. Gereç ve Yöntemler: Bu retrospektif çalışmaya Ocak 2014-Aralık 2018 tarihleri arasında opere olmuş 150 metastatik olmayan meme kanserli hasta dahil edildi. RPR düzeyinin hastalıksız sağkalım (HSK) için optimum cutoff değeri 0,54 olarak alındı. RPR ve klinikopatolojik değişkenler arasındaki ilişkiyi değerlendirmek için ki kare ve Fisher exact testleri kullanıldı. Değişkenlerin HSK etkisini saptamak için Kaplan-Meier log-rank testi kullanıldı. Multivariate analiz için Cox oransal hazards modeli kullanıldı. Bulgular: Hastaların median takip süresi 39±1,174 (13-66) ay idi. 5 yıllık sağkalım %96,60 idi. RPR ile klinikopatalojik değişkenler arasında ilişki saptanmadı. Kaplan-Meier analizinde yüksek RPR düzeyi (p<0,001) ve yüksek ortalama trombosit hacminin trombositlere oranı (MPV/P) (p=0,006) ile HSK arasında anlamlı ilişki saptandı. Yüksek RPR düzeyi ve yüksek MPV/P oranı olan hastalarda HSK kısa saptandı. Cox regresyon analizi ile multivariate analiz yapıldığında RPR (p=0,025) ve tümör çapı (p=0,047) bağımsız prognostik faktörler olarak tespit edildi. RPR'nin, MPV/P oranına göre daha değerli bir prognostik belirteç olduğu saptandı. Sonuç: Bu çalışmada, küratif rezeksiyon yapılmış meme kanserli hastalarda adjuvan tedavi öncesi yüksek RPR düzeylerinin kötü HSK ile ilişkili olduğu saptanmıştır. Metastatik olmayan meme kanserli hastalarda , RPR düzeyi prognostik bir marker olarak kullanılabilir, ancak daha fazla hasta sayısı ile yapılacak çalışmalara ihtiyaç vardır.
Anahtar Kelimeler: Meme kanseri; kırmızı küre dağılım genişliği; trombosit; prognoz
- Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151-64. [Crossref] [PubMed] [PMC]
- Zendehdel M, Niakan B, Keshtkar A, Rafiei E, Salamat F. Subtypes of benign breast disease as a risk factor for breast cancer: a systematic review and meta-analysis protocol. Iran J Med Sci. 2018;43(1):1-8.
- Cao SS, Lu CT. Recent perspectives of breast cancer prognosis and predictive factors. Oncol Lett. 2016;12(5):3674-8. [Crossref] [PubMed] [PMC]
- Goncalves R, Bose R. Using multigene tests to select treatment for early-stage breast cancer. J Natl Compr Canc Netw. 2013;11(2):174-82. [Crossref] [PubMed]
- Forhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659-66. [Crossref] [PubMed]
- Seretis C, Seretis F, Lagoudianakis E, Gemenetzis G, Salemis NS. Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study. J Clin Med Res. 2013;5(2):121-6. [Crossref]
- Beyazit Y, Kekilli M, Ibis M, Kurt M, Sayilir A, Onal IK, et al. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis. Hepatogastroenterology. 2012;59(117):1469-73.
- Baicus C, Caraiola S, Rimbas M, Patrascu R, Baicus A; for Grupul de Studiu al Scaderii Ponderale I. Utility of routine hematological and inflammation parameters for the diagnosis of cancer in involuntary weight loss. J Investig Med. 2011;59(6):951-5. [Crossref] [PubMed]
- Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One. 2013;8(11):e80240. [Crossref] [PubMed] [PMC]
- Ichinose J, Murakawa T, Kawashima M, Nagayama K, Nitadori JI, Anraku M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer. J Thorac Dis. 2016;8(12):3658-66. [Crossref] [PubMed] [PMC]
- Qin Y, Wang P, Huang Z, Huang G, Tang J, Guo Y, et al. The value of red cell distribution width in patients with ovarian cancer. Medicine (Baltimore). 2017;96(17):e6752. [Crossref] [PubMed] [PMC]
- Bilgin B, Sendur MAN, Hizal M, Dede DS, Akinci MB, Kandil SU, et al. Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization. J Cancer Res Ther. 2019;15(1):54-60.
- Takeuchi H, Abe M, Takumi Y, Hashimoto T, Miyawaki M, Okamoto T, et al. Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer. Sci Rep. 2019;9(1):3033. [Crossref] [PubMed] [PMC]
- Sun P, Zhang F, Chen C, Bi X, Yang H, An X, et al. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget. 2016;7(27):42650-60. [Crossref] [PubMed] [PMC]
- Nishizaki Y, Yamagami S, Suzuki H, Joki Y, Takahashi S, Sesoko M, et al. Red blood cell distribution width as an effective tool for detecting fatal heart failure in super-elderly patients. Intern Med. 2012;51(17):2271-6. [Crossref] [PubMed]
- Karabulut A, Uzunlar B. Correlation between red cell distribution width and coronary ectasia in the acute myocardial infarction. Clin Appl Thromb Hemost. 2012;18(5):551-2. [Crossref] [PubMed]
- Yesil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdas Ovunc AO. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver. 2011;5(4):460-7. [Crossref] [PubMed] [PMC]
- Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol. 2012;590(5):1023-34. [Crossref] [PubMed] [PMC]
- Warwick R, Mediratta N, Shackcloth M, Shaw M, McShane J, Poullis M. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(1):108-13. [Crossref] [PubMed]
- Allen MD, Jones LJ. The role of inflammation in progression of breast cancer: friend or foe? (Review). Int J Oncol. 2015;47(3):797-805. [Crossref] [PubMed]
- Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9(2):237-49. [Crossref] [PubMed]
- Voutsadakis IA. Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J Gastrointest Oncol. 2014;6(2):34-40. [Crossref] [PubMed] [PMC]
- Zhang Y, Lu JJ, Du YP, Feng CX, Wang LQ, Chen MB. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine (Baltimore). 2018;97(12):e0144. [Crossref] [PubMed] [PMC]
- Taefi A, Huang CC, Kolli K, Ebrahimi S, Patel M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int. 2015;9(3):454-60. [Crossref] [PubMed]
- Cetinkaya E, Senol K, Saylam B, Tez M. Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol. 2014;20(39):14450-4. [Crossref] [PubMed] [PMC]
- Pusuroglu H, Cakmak HA, Akgul O, Erturk M, Surgit O, Akkaya E, et al. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Rev Port Cardiol. 2015;34(10):597-606. [Crossref] [PubMed]
.: İşlem Listesi